Next-generation drug from Eli Lilly boosts weight loss to 24% ... - CNN
Jun 26, 2023 · An experimental drug from Eli Lilly helped patients with obesity lose an average of 24% of their body weight over 48 weeks on the highest dose in a mid-stage study, the most weight loss seen...
Biden proposes weight loss drug coverage requirements for ... - NBC News
Nov 26, 2024 · Weight loss drugs like Wegovy, Zepbound and Ozempic would be covered by Medicare and Medicaid under a Biden administration proposal.
2024 Was The Year-Weight Loss Drugs Took Over - Bloomberg
21 hours ago · After decades of ineffective fad diets and crushing social stigma, a weight-loss shot years changed everything. Seemingly overnight, millions of people were taking the medicines, known as GLP-1s.
FDA says shortage of weight loss drugs manufactured by Eli Lilly …
2 days ago · "FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 drugs, including semaglutide and tirzepatide, as an option for weight loss," the FDA said ...
Zepbound sheds more weight than Wegovy in trial, Eli Lilly says - NBC News
Dec 4, 2024 · People who took Zepbound, Eli Lilly’s weight loss drug, shed more pounds than those on Novo Nordisk’s Wegovy in a head-to-head clinical trial, Lilly said in a news release Wednesday.
GLP-1 pills are coming, and they could revolutionize weight-loss …
Sep 17, 2024 · At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, with the most advanced now in the third and final stage of...
What the results of Wegovy’s longest clinical trial yet show about ...
May 13, 2024 · New analyses of the longest clinical trial yet of the weight-loss drug Wegovy are shedding light on how quickly it helps people lose weight, how long they sustain that weight loss and how safe...
Biden proposes Medicare and Medicaid cover weight-loss drugs | AP News
Nov 26, 2024 · Millions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare or Medicaid under a new rule the Biden administration proposed Tuesday morning.
FDA approves Eli Lilly’s Zepbound, a weight loss drug ... - NBC News
Nov 8, 2023 · The FDA has approved Zepbound, an injectable weight loss drug from Eli Lilly that helped people lose up to 52 lbs in 16 months during clinical trials.
F.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep …
6 days ago · Last March, the F.D.A. approved Wegovy, a weight loss drug from Novo Nordisk, to reduce the risk of cardiovascular issues in people with obesity. Dani Blum is a health reporter for The Times.